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Abstract
Background: Over 20 years, from October 1989, the Darwin prospective melioidosis study has documented 540 cases from
tropical Australia, providing new insights into epidemiology and the clinical spectrum.
Principal Findings: The principal presentation was pneumonia in 278 (51%), genitourinary infection in 76 (14%), skin
infection in 68 (13%), bacteremia without evident focus in 59 (11%), septic arthritis/osteomyelitis in 20 (4%) and
neurological melioidosis in 14 (3%). 298 (55%) were bacteremic and 116 (21%) developed septic shock (58 fatal). Internal
organ abscesses and secondary foci in lungs and/or joints were common. Prostatic abscesses occurred in 76 (20% of 372
males). 96 (18%) had occupational exposure to Burkholderia pseudomallei. 118 (22%) had a specific recreational or
occupational incident considered the likely infecting event. 436 (81%) presented during the monsoonal wet season. The
higher proportion with pneumonia in December to February supports the hypothesis of infection by inhalation during
severe weather events. Recurrent melioidosis occurred in 29, mostly attributed to poor adherence to therapy. Mortality
decreased from 30% in the first 5 years to 9% in the last five years (p,0.001). Risk factors for melioidosis included diabetes
(39%), hazardous alcohol use (39%), chronic lung disease (26%) and chronic renal disease (12%). There was no identifiable
risk factor in 20%. Of the 77 fatal cases (14%), 75 had at least one risk factor; the other 2 were elderly. On multivariate
analysis of risk factors, age, location and season, the only independent predictors of mortality were the presence of at least
one risk factor (OR 9.4; 95% CI 2.3–39) and age $50 years (OR 2.0; 95% CI 1.2–2.3).
Conclusions: Melioidosis should be seen as an opportunistic infection that is unlikely to kill a healthy person, provided
infection is diagnosed early and resources are available to provide appropriate antibiotics and critical care.
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Introduction
Melioidosis is the clinical disease following infection with the soil
and water bacterium Burkholderia pseudomallei [1,2]. It occurs in
humans and a wide variety of animals and is thought to usually
follow percutaneous inoculation. In addition, inhalation of
aerosolized bacteria probably occurs during severe weather events
such as tropical storms, aspiration is documented with near
drowning and ingestion can occur, especially in grazing animals
but also from mastitis-associated infected breast milk [3,4].
Zoonotic transmission is described but is exceedingly uncommon,
as are person-to-person transmission, nosocomial transmission and
laboratory-acquired infection.
While melioidosis can present as a rapidly fatal septicemic illness
and B. pseudomallei is now considered a potential biothreat agent,
there remain major gaps in understanding the global distribution,
epidemiology and pathogenesis of this infection. The known
endemic distribution of B. pseudomallei is expanding well beyond the
traditional melioidosis-endemic regions of Southeast Asia and
northern Australia, with recent case reports of melioidosis from the
Americas, Madagascar, Mauritius, India and elsewhere in south
Asia, China and Taiwan [5,6]. It remains unclear to what extent
this reflects true expansion of endemicity rather than unmasking of
the long-standing environmental presence of the bacterium.
Since October 1989 we have prospectively documented all cases
of melioidosis in the tropical ‘‘Top End’’ of the Northern Territory
of Australia. We described the presentations of the first 252 cases
after 10 years of the Darwin prospective melioidosis study [7] and
we now present the findings from 540 cases over 20 years.
Materials and Methods
This study was approved by the Human Research Ethics
Committee of the Northern Territory Department of Health and
Families and the Menzies School of Health Research (HREC 02/
38) and data were analysed anonymously. The Top End has a
population of around 150,000 in an area of 516,945 km2, with
almost 125,000 living in the Northern Territory capital city of
Darwin (12uS). All patients with culture-confirmed melioidosis in
the Top End from October 1st 1989 until September 30th 2009
were included. Investigation, treatment and follow-up were
supervised in all cases in consultation with the Infectious Disease
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Department at Royal Darwin Hospital, the 350 bed referral
hospital for the Top End. We followed all patients until death or
after completion of therapy. Hazardous alcohol use was defined as
greater than an average daily consumption of six standard drinks
(60 g alcohol total) for males and four (40g alcohol total) for
females. Chronic lung disease was defined as a documented
diagnosis of chronic obstructive airways disease. Chronic renal
disease was defined as a creatinine of .150 umol/L (N.
R.,90 umol/L) before the melioidosis illness or after completion
of therapy if not previously documented. Septic shock was defined
as the presence of hypotension not responsive to fluid replacement
together with hypoperfusion abnormalities manifest as end organ
dysfunction [8].
Patient details were stored in a database and analysed using Stata
version 10 (Stata Corporation, Texas). Chi-squared or Fisher exact
tests were used to assess categorical variables; p,0.05 was
considered significant and risk ratios and 95% confidence intervals
were then calculated. To identify associations with a fatal outcome
and with presentation with pneumonia and with bacteremia we
conducted multivariable logistic regression analyses with stepwise
backwards elimination of patient demographic and risk factor
variables, with odds ratios and 95% confidence intervals calculated.
Results
There were 540 cases and 77 deaths (14%) attributable to
melioidosis over the 20 years. Ages ranged from 8 months to 91
years (median 49 years). There were 26 children #15 years old
(5%) and two of these died, one with congenital heart disease and
one with severe rheumatic heart disease. 372 patients (69%) were
male and 281 Indigenous Australians (52%). 262 patients (49%)
lived in the suburbs of Darwin, 65 (12%) on rural properties
(‘‘blocks’’) outside Darwin city, 37 (7%) in the regional towns of
Katherine and Nhulunbuy and 169 (31%) in remote Indigenous
communities. Four infections were considered acquired in sub-
tropical central Australia and three were acquired elsewhere in
tropical northern Australia outside the Northern Territory.
Table 1 shows patient risk factors and outcomes by risk factor.
There were only 2 patients with confirmed HIV infection,
although a small number were not tested and 1 patient was
seropositive for HTLV-I. Mortality was significantly higher in
those with chronic respiratory disease (19% vs 13%; risk
ratio = 1.5 (95% CI 1.1–2.4); p = 0.048). Although no other
individual risk factor, including diabetes, was predictive of
mortality, the absence of any risk factors was strongly predictive
of survival; of the 106 (20%) with no identified risk factor for
melioidosis, only two died (2%); both elderly, aged 75 and 82
years, respectively.
407 patients (75%) were considered to have exposure to
environmental B. pseudomallei through their recreational activities
and 96 (18%) had direct exposure through occupational activities
including gardening and outdoor maintenance, plumbing, build-
ing construction, plant machine operation and military exercises.
Only 103 (19%) had no evident environmental or recreational
exposure. In 118 (22%) cases there was a specific exposure
scenario that was considered the likely infecting event. These
included skin wounds sustained whilst working outdoors or
gardening, or while playing sports such as soccer and rugby on
muddy playing fields, or while fishing in fresh water rivers, hunting
such as chasing feral pigs through tropical savannah swamps and
motor vehicle accidents involving wet soil exposure. Several cases
were in disabled people who rarely ventured outside their
accommodation but were potentially exposed to aerosolised
bacteria during storms. Regional clusters of cases occurred
following severe weather events such as the Katherine river flood
in January 1998, and Category 5 tropical cyclone Thelma, which
hit the Tiwi Islands in December 1998 [9]. One cluster with nine
cases of melioidosis and four deaths was attributed to confirmed B.
pseudomallei contamination of the un-chlorinated water supply in a
remote Aboriginal community [10].
Overall 436 (81%; 95%CI 77%–84%; p,0.005) presented
during the wet season (November 1st–April 30th) and mortality was
higher in cases presenting in January (23/102 (23%) died;
p = 0.007) than in other months. Pneumonia was a significantly
more common presentation in the peak monsoonal months of
December to February (172/280; 61%) than in the other 9 months
(106/260; 41%; p,0.001).
Of all presentations, 461 (85%) were considered acute (defined
as symptoms present for less than 2 months) and from recent
infection. 60 (11%) were chronic in nature (defined as symptoms
present for over 2 months; 25 pneumonia, 23 skin ulcer(s), 12
others). These chronic infections were considered to be mostly
acquired during the current or preceding wet season, with the
delay until presentation explaining some of the cases diagnosed
during the dry season. 17 of the 53 (32%) cases who presented
during the mid dry season months of June 1st to September 30th
fulfilling the definition for chronic melioidosis. Patients with
chronic melioidosis were less likely to be diabetic than those with
acute melioidosis (20% vs 42%; p,0.001), with 42% having no
identified risk factor in comparison to 17% of those with acute
disease (p,0.001). Only 1 of 60 patients (2%) with chronic
melioidosis died (p,0.001).
The remaining 19 (4%) patients were thought to have
reactivation of disease from a latent focus of B. pseudomallei
infection, based on long-standing prior radiological abnormalities
and/or known long-standing positive melioidosis serology (13
pneumonia, 2 bacteremia no focus, 2 genitourinary infection, 1
each soft tissue infection and skin abscess). Those with presumptive
reactivated melioidosis were more likely to have underlying
chronic lung disease (47% compared with 25% for all others;
p = 0.03) and rheumatic heart disease and/or congestive cardiac
Author Summary
Melioidosis is an occupationally and recreationally ac-
quired infection important in Southeast Asia and northern
Australia. Recently cases have been reported from more
diverse locations globally. The responsible bacterium,
Burkholderia pseudomallei, is considered a potential
biothreat agent. Risk factors predisposing to melioidosis
are well recognised, most notably diabetes. The Darwin
prospective melioidosis study has identified 540 cases of
melioidosis over 20 years and analysis of the epidemiology
and clinical findings provides important new insights into
this disease. Risk factors identified in addition to diabetes,
hazardous alcohol use and chronic renal disease include
chronic lung disease, malignancies, rheumatic heart
disease, cardiac failure and age $50 years. Half of patients
presented with pneumonia and septic shock was common
(21%). The decrease in mortality from 30% in the first 5
years of the study to 9% in the last five years is attributed
to earlier diagnosis and improvements in intensive care
management. Of the 77 fatal cases (14%), all had known
risk factors for melioidosis. This supports the most
important conclusion of the study, which is that melioi-
dosis is very unlikely to kill a healthy person, provided the
infection is diagnosed early and resources are available to
provide appropriate antibiotics and critical care where
required.
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failure (32% compared with 6% for all others; p,0.001) and 5/19
of these died (26% compared with 14% for all others; p = 0.13).
The clinical presentations and outcomes are shown in Table 2.
Overall 298 (55%) patients were bacteremic. Pneumonia was the
commonest principal clinical presentation on admission (278
cases; 51%), followed by genitourinary infection (76 cases; 14%)
and skin infection (68 cases; 13%). There were 20 (4%) patients
presenting with septic arthritis and/or osteomyelitis and 14 (3%)
with neurological melioidosis, of whom 10 presented with
meningo-encephalitis, 2 with myelitis and 2 with cerebral
abscesses. Bacteremia without an evident clinical focus was also
a common presentation (59 cases; 11%), with severity of illness
ranging from rapidly fatal septic shock to a clinically very mild
febrile illness. When septic shock occurred it was usually present
on or within 24 hours of admission. Of the 116 patients (21%)
with septic shock, 58 (50%) died from acute fulminant melioidosis.
In contrast, for those without septic shock on presentation, mortality
was 4% overall (19/424); even in the 195 of those without septic
Table 2. Clinical presentations and outcomes of 540 cases of melioidosis.
Total Bacteremic Non-bacteremic
Number Deaths (Mortality) Number Deaths (Mortality) Number Deaths (Mortality)
Septic shock 116 (21%) 58 (50%) 103 48 (47%) 13 10 (77%)
Pneumonia 88 43 (49%) 78 35 (45%) 101 8 (80%)
No evident focus 13 8 (62%) 12 7 (58%) 12 1 (100%)
Genitourinary 10 5 (50%) 9 4 (44%) 13 1 (100%)
Osteomyelitis/septic arthritis 4 2 (50%) 4 2 (50%) 0 0 (0%)
Soft tissue abscess 1 0 (0%) 0 0 1 0 (0%)
Non-septic shock 424 (79%) 19 (4%) 195 13 (7%) 229 6 (3%)
Pneumonia 190 12 (6%) 89 9 (10%) 101 3 (3%)
Skin infection 68 0 (0%) 1 0 (0%) 67 0 (0%)
Genitourinary 66 2 (3%) 41 2 (5%) 25 0 (0%)
No evident focus 52 2 (4%) 47 2 (4%) 5 0 (0%)
Soft tissue abscess(es) 18 0 (0%) 4 0 (0%) 14 0 (0%)
Osteomyelitis/septic arthritis 16 0 (0%) 10 0 (0%) 6 0 (0%)
Neurological 14 3 (21%) 3 0 (0%) 11 3 (27%)
Total 540 77 (14%) 298 (55%) 61 (20%) 242 (45%) 16 (7%)
17 blood cultures not done, 3 blood cultures negative.
2Culture +ve for B. pseudomallei only from rectal swab, although fatal septic shock.
3blood culture not done.
doi:10.1371/journal.pntd.0000900.t002
Table 1. Risk factors for 540 patients with melioidosis.
Patients Deaths
Risk factor n % of total n % who died
Diabetes 213 39% 33 15%4
Hazardous alcohol use 211 39% 33 16%4
Chronic lung disease 140 26% 27 19%5
Chronic renal disease 65 12% 13 20%4
Rheumatic heart disease and/or congestive cardiac failure 39 7% 9 23%4
Malignancy 31 6% 8 26%4
Immunosuppressive therapy and other immunosuppression1 31 6% 6 20%4
Kava use 27 5% 4 15%4
Other2 6 1% 2 33%4
No risk factors 106 20% 23 2%6
1Mostly patients taking prednisolone therapy. Two with HIV infection and 1 with HTLV-I infection.
2Three with hepatitis B-related chronic liver disease, 1 with hemochromatosis and chronic liver disease, 1 with other chronic liver disease and 1 with multiple strokes and
prior aspiration pneumonia.
3Both elderly; ages 75 and 82 years old but no other apparent risk factors for melioidosis.
4Not significant in comparison to those without the risk factor.
5Risk ratio = 1.5 (95% CI 1.1–2.4) in comparison to those without chronic lung disease; p = 0.048.
6Risk ratio = 0.11 (95%CI 0.03–0.44) in comparison to presence of any risk factor; p,0.001.
doi:10.1371/journal.pntd.0000900.t001
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shock who were bacteremic, only 13 (7%) died. Of the 106 patients
with no identified risk factor, 23 (22%) were bacteremic and 6 (6%)
had septic shock and the only deaths in this group were the 2 elderly
patients as already noted.
Table 3 shows significant risk factors in the 278 melioidosis
patients with a primary presentation of pneumonia. On univariate
analysis age $50 years, diabetes, excessive alcohol consumption
and rheumatic heart disease and/or congestive cardiac failure
were each associated with a propensity for presentation with
pneumonia in comparison to other presentations. However on
multivariable analysis diabetes and age were not independent
predictors of a presentation with pneumonia, while chronic lung
disease, excessive alcohol consumption and rheumatic heart
disease and/or congestive cardiac failure were.
Table 4 lists internal organ abscesses and other foci of infection.
Following findings early in the study of frequent internal
collections, CT scanning of abdomen and pelvis has been routinely
performed on all patients with melioidosis since around 1995.
Prostatic abscesses were present in 76 males (20%), the majority of
which required drainage [11]. In comparison to case series from
Thailand, hepatic abscesses were uncommon and as with splenic
and renal abscesses rarely required drainage. Three women had
mastitis and three men had epididymo-orchitis. Lymphadenitis
(sometimes suppurating), muscle abscesses, diffuse myositis and
cellulitis were all seen but were uncommon. Four patients had para-
intestinal masses which were considered possible primary infection
following ingestion of B. pseudomallei, as was a presentation with a
ruptured large gastric ulcer with subphrenic abscess and suppura-
tive peritonitis. Mediastinal widening on chest X-ray and CT scan
was seen, sometimes with clearly enlarged mediastinal lymph nodes
and usually in association with pneumonia (12/17 cases). Four
patients had suppurative pericarditis, three with contiguous
pulmonary infection and one without evident pulmonary infection
who developed acute pericardial tamponade requiring emergency
thoracotomy and a pericardial window. Two had mycotic pseudo-
aneurysms and one woman presented with a ruptured uterus from
a massive uterine wall abscess.
In addition to the initial principal clinical presentation,
subsequent clinically-evident secondary foci were not uncommon
and examples are shown in Table 5. Secondary pneumonia was
especially common in those presenting with genitourinary
infection, septic arthritis/osteomyelitis and bacteremia without
an apparent clinical focus, but was unusual in those presenting
with skin infection. Secondary foci were also less common in those
presenting with pneumonia, although brain abscesses and septic
arthritis requiring surgery occurred in this group. Of note, the
pattern of secondary neurological melioidosis was different from
the encephalomyelitis seen as a primary presentation. Of the eight
patients with secondary neurological disease, all were blood
culture positive (in comparison to 3/14 of those with primary
neurological melioidosis; p = 0.001) and 5 had abscesses (4
intracranial, 1 spinal cord).
121 patients (22%) were admitted to the Royal Darwin Hospital
Intensive Care Unit (ICU) and of these 40 (33%) died. In the ICU
97 were ventilated (41 died; 42%) (Table 6) and 60 received
granulocyte colony-stimulating factor (G-CSF) (15 died; 25%).
Three patients also received activated protein C therapy (1 died).
Of the 77 deaths overall, 75 were during the initial hospital
admission, with the time from admission to death in these ranging
from 0 to 111 days (median 3 days). Two patients were dead on
arrival at hospital, 8 died on the day of admission, and 7 died the
day after admission.
Table 3. Risk factors in 278 patients presenting with melioidosis pneumonia.
Patients
Primary
Pneumonia Univariate Multivariate
n % n % p OR 95% CI p OR 95% CI
Age $50 y
No 277 51% 130 47% ns
Yes 263 49% 148 56% 0.030 1.3 (1.04–2.0)
Diabetes
No 327 61% 156 48% ns
Yes 213 39% 122 57% 0.030 1.5 (1.04–2.1)
Hazardous alcohol use
No 329 61% 154 47%
Yes 211 39% 124 59% 0.007 1.6 (1.1–2.3) 0.041 1.5 (1.02–2.1)
Chronic lung disease
No 400 74% 181 45%
Yes 74 26% 97 69% ,0.001 1.5 (1.3–1.8) ,0.001 2.5 (1.6–3.9)
RHD/CCF
No 501 93% 248 50%
Yes 39 7% 30 77% 0.001 3.4 (1.6–7.2) 0.009 2.8 (1.3–6.2)
Kava use
No 513 95% 272 53%
Yes 27 5% 6 22% 0.002 0.3 (0.1–0.6) 0.004 0.2 (0.1–0.6)
RHD/CCF; rheumatic heart disease and/or congestive cardiac failure.
ns; not significant.
doi:10.1371/journal.pntd.0000900.t003
20 Years of Melioidosis in Tropical Australia
www.plosntds.org 4 November 2010 | Volume 4 | Issue 11 | e900
Of the 465 patients surviving the initial infection, 30 (6%) re-
presented with culture-confirmed recurrent melioidosis subsequent
to completion of antibiotic therapy, with 2 deaths in this group. Of
these 30, 25 were considered to have relapse of an unsuccessfully
eradicated infection, usually resulting from poor adherence to
antimicrobial therapy. In these cases, the time from initial
admission to first relapse was 3.6–28 months (median 8 months),
with one of these patients dying. Two of these patients had a
second relapses (25 and 27 months after their first relapse); one of
these patients died during the second relapse and the other patient
had a third relapse 5 years after the second relapse. For those
surviving the initial admission, diabetes was more common in
those who relapsed (16/25 (64%) vs 166/440 (38%); p = 0.016), as
was bacteremia on admission (18/25 (72%) vs 221/440 (50%);
p = 0.034).
There were 5 patients with recurrent melioidosis where the B.
pseudomallei isolates were different from the original isolate by
pulsed-field gel electrophoresis or multilocus sequence typing
(MLST). One patient with cystic fibrosis had three separate
presentations with melioidosis at ages 10, 14 and 18 years. There
was a good response to therapy each episode, with each B.
pseudomallei isolate being a different sequence type (ST) and
frequent sputum cultures between episodes being consistently
culture negative for B. pseudomallei. He was considered to have been
re-infected on three separate occasions. Three other patients with
recurrent melioidosis but disparate isolates on typing were also
considered likely to have new infections, occurring 14, 58 and 72
months after the initial infection, respectively. One further patient
had disparate isolates on MLST from presentations 8 months
apart and was thought to have relapse of a probable initial
infection with multiple B. pseudomallei strains, with the osteomyelitis
of the second presentation being evident clinically during the first
presentation. Clinically apparent re-infection with B. pseudomallei is
therefore thought to have occurred in only 4/465 (1%) patients
surviving the initial admission, despite most survivors remaining in
the melioidosis-endemic location, with many having persisting risk
factors and continuing environmental exposure to B. pseudomallei.
Of the 463 patients who did not die from melioidosis, all except
one have eventually cleared their infection with antibiotic therapy.
This is a patient with moderately severe bronchiectasis who
presented with a productive cough at age 61 years, with B.
pseudomallei cultured from sputum. Her sputum has remained
consistently B. pseudomallei culture positive for 8 years, despite
multiple courses of intravenous and prolonged oral antibiotics and
also a lobectomy of the most severely bronchiectatic lung lobe. She
nevertheless remains generally well.
Table 6 shows decreasing mortality over the 20 years of the
study that was not explained by either increasing recruitment of
less sick patients or fewer risk factors in patients. To further assess
associations with mortality we included the following categorical
variables in the initial logistic regression model; age ($50 years),
indigenous ethnicity, each of the risk factors from Table 1,
location, and presentation in December, January or February. No
individual risk factor was a significant independent predictor of
mortality (data not shown), although in a similar logistic regression
model with bacteremia as the outcome, independent predictors of
bacteremia were indigenous ethnicity, age $50 years, diabetes,
Table 5. Secondary clinical foci for major primary diagnostic groups.
Primary diagnosis Total number
Number with secondary
foci (% of total) More common secondary foci1
Pneumonia 278 41 (15%) 17 prostatic abscesses, 10 splenic abscesses, 7 septic
arthritis, 6 neurological, 6 liver abscesses, 5 renal abscesses
Genitourinary 76 26 (34%) 17 pneumonia, 3 splenic abscesses, 2 liver abscesses
Skin infection 68 6(9%) 3 pneumonia, 2 splenic abscesses, 2 liver abscesses
Bacteremia, no initial focus 59 25 (42%) 13 pneumonia, 6 splenic abscesses, 4 septic arthritis, 3
prostatic abscesses, 2 liver abscesses, 2 osteomyelitis, 2
neurological, 1 renal abscess
Osteomyelitis/septic arthritis 20 11 (55%) 6 pneumonia, 3 splenic abscesses
Soft tissue abscess(es) 19 9 (47%) 3 pneumonia, 2 septic arthritis, 2 osteomyelitis, 2 splenic
abscesses
Neurological melioidosis 14 5 (36%) 3 pneumonia
1more than 1 secondary focus found in some cases.
doi:10.1371/journal.pntd.0000900.t005
Table 4. Internal organ abscesses and other foci of infection
in 540 patients with melioidosis.
Site n %
Prostatic abscess(es) 76 20%1
Splenic abscess(es) 28 5%
Kidney abscess(es) 18 3%
Liver abscess(es) 15 3%
Adrenal abscess 3 ,1%
Psoas abscess(es) 4 ,1%
Other muscle abscess/myositis 8 1%
Cellulitis 3 ,1%
Lymphadenitis 9 2%
Mediastinal mass 17 3%
Pericarditis 4 ,1%
Para-intestinal mass 4 ,1%
Mastitis 3 ,1%
Epididymo-orchitis 3 ,1%
Mycotic (pseudo)aneurysm 2 ,1%
1calculated for males only.
doi:10.1371/journal.pntd.0000900.t004
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hazardous alcohol use, chronic renal disease, malignancy and
immunosuppression (Table 7). Therefore our final model for
mortality from melioidosis incorporated presence or absence of
any of the defined risk factors as a dichotomous variable. In this
model the independent factors associated with mortality were age
$50 years (OR 2.0; 95% CI 1.2–3.3) and presence of any risk
factor (OR 9.4; 95% CI 2.3–39), but not indigenous ethnicity,
geographical location or season (Table 8).
Discussion
Serological surveys suggest that most infections with B.
pseudomallei are asymptomatic, with over half of teenagers
seropositive in the highly endemic region of northeast Thailand
[12]. It was estimated that for children in northeast Thailand
approximately 1 in 4600 antibody-producing exposures results in
clinical infection [13]. The Darwin prospective melioidosis study
Table 6. Changing outcomes over the 20 years.
First 5 years Second 5 years Third 5 years Fourth 5 years Total over 20 years
Number 88 164 139 149 540
Died (%)1 26 (30%) 24 (15%) 14 (10%) 13 (9%) 77 (14%)
Blood culture +ve (% of total) 40 (45%) 77 (47%) 83 (60%) 98 (66%) 298 (55%)
Septic shock (% of total) 16 (18%) 28 (17%) 39 (28%) 33 (22%) 116 (21%)
Septic shock and died (% mortality)1 16 (100%) 21 (75%) 12 (31%) 9 (27%) 58
Ventilated (% of total) 8 (9%) 22 (13%) 34 (24%) 33 (22%) 97 (18%)
Ventilated and died (% mortality)2 8 (100%) 16 (73%) 8 (24%) 9 (27%) 41
Median age (years) 51y 49y 49y 49y 49y
Indigenous (%) 40 (45%) 90 (55%) 63 (45%) 87 (59%)
Diabetic (%) 37 (42%) 56 (34%) 55 (40%) 65 (44%) 213 (39%)
No risk factors 15 (17%) 39 (24%) 26 (19%) 26 (17%) 106 (20%)
1Significant trend for lower mortality over time; p,0.001 Chi-squared test of trend for proportion.
2Significant trend for lower mortality over time; p = 0.002 Chi-squared test of trend for proportion.
doi:10.1371/journal.pntd.0000900.t006
Table 7. Associations with bacteremia.
Patients Bacteremic Univariate Multivariate
n % N % p OR 95% CI p OR 95% CI
Indigenous
No 259 48% 112 44%
Yes 281 52% 186 67% ,0.001 2.7 (1.9–3.8) ,0.001 3.2 (2.1–4.9)
Age $50 y
No 277 51% 131 48%
Yes 263 49% 167 64% ,0.001 1.9 (1.4–2.7) ,0.001 2.3 (1.5–3.6)
Diabetes
No 327 61% 152 47%
Yes 213 39% 146 70% ,0.001 2.6 (1.8–3.7) ,0.001 2.2 (1.4–3.2)
Hazardous alcohol use
No 329 61% 166 51%
Yes 211 39% 132 64% 0.004 1.7 (1.2–2.4) 0.014 1.6 (1.1–2.4)
Chronic renal disease
No 475 88% 247 53%
Yes 65 12% 51 78% ,0.001 3.2 (1.8–6.0) 0.019 2.2 (1.1–4.3)
Malignancy
No 509 94% 274 55%
Yes 31 6% 24 77% 0.013 2.8 (1.2–6.6) 0.003 4.1 (1.6–11)
Immuno-suppression
No 509 94% 275 55%
Yes 31 6% 23 75% 0.036 2.4 (1.1–5.3) 0.028 2.7 (1.1–6.5)
doi:10.1371/journal.pntd.0000900.t007
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provides strong support for the vast majority of melioidosis cases
being from recent infection, with 81% of cases presenting during
the monsoonal wet season, similar to a figure of 75% in Thailand
[14]. Nevertheless latency of B. pseudomallei with subsequent
reactivation is well recognised, being described as long as 62
years after infection in a returned World War II prisoner of war
infected in southeast Asia [15]. It was estimated from serology
studies that following the Vietnam War around 225,000 US
service personnel may have been infected with B. pseudomallei [16].
This was called the ‘‘Vietnamese time bomb’’, but the subsequent
number of melioidosis cases following return to the USA has been
comparatively small. Reactivation from a latent focus was
considered to have occurred in only 19/540 (4%) cases in the
Darwin study.
We previously estimated the average annual incidence rate of
melioidosis in the Top End of the Northern Territory to be 19.6
cases per 100,000 population, with an estimated rate in diabetics
of 260 cases per 100,000/year [17]. Yearly rates between 1990
and 2002 ranged from a low of 5.4/100,000 in 1993 to a high of
41.7/100,000 in 1998, a year with two severe tropical cyclones
with intense rainfall and winds. This compares to northeast
Thailand, with an average annual melioidosis incidence rate
between 1997 and 2006 of 12.7/100,000 and with a highest rate of
21.3/100,000 in 2006 [18].
In the Darwin study 75% of melioidosis cases reported
recreational activities that would result in exposure to environ-
mental B. pseudomallei and 18% had clear occupational exposure.
Both males (69%) and indigenous Australians (52%) were over-
represented, most likely reflecting increased environmental
exposure. There were 118 cases (22%) where history revealed a
likely specific infecting event. B. pseudomallei is common in the
urban environment of Darwin and most of the 49% of patients in
the study who lived in the city of Darwin were infected in the city
environs, including domestic gardens and yards. Mortality in the
Darwin study was not linked to geographical location, being
actually higher (although not statistically significantly so) in the
urban population than in the rural and remote population
(Table 8). In contrast, in northeast Thailand 81% of cases of
melioidosis were in rural rice farmers and their children [14]. In
Singapore melioidosis has occurred in construction workers,
gardeners and military personnel, but in that tropical island city
state, where over 80% of people live in high-rise apartments, the
reasons for infection often remain unclear [19].
Earlier in the Darwin prospective melioidosis study we
established that the incubation period for acute melioidosis
following specific infecting events was 1–21 days (mean, 9 days)
[20]. The incubation period, clinical presentations of melioidosis
and outcomes are thought to be determined by a combination of
bacterial load infecting the individual, putative B. pseudomallei strain
differences in virulence, mode of infection and, most importantly
host risk factors for disease [21]. For instance, less severe disease
with symptoms present for over 2 months before presentation
(chronic melioidosis) was significantly less common in diabetics
and was more commonly seen in those without underlying risk
factors.
The association between inhalation as a route of acquisition and
increased severity of disease with higher mortality than percuta-
neous exposure is well recognised for anthrax, plague and
tularaemia, but appears to have been under-appreciated in
melioidosis. While the association between melioidosis and rainfall
is well established [14] and there is epidemiological support for
inhalation of aerosolised B. pseudomallei during severe weather
events resulting in a pneumonic presentation with higher mortality
[9,19,22], the overall contribution of inhalation of B. pseudomallei in
comparison to percutaneous inoculation remains entirely unclear.
Support for inhalation of B. pseudomallei from this study includes
Table 8. Associations with mortality.
Patients Deaths Univariate Multivariate
n % n % died p OR 95% CI p OR 95% CI
Age $50 y
No 277 51% 26 9%
Yes 263 49% 51 19% 0.001 2.3 (1.4–3.9) 0.009 2.0 (1.2–3.3)
Indigenous
No 259 48% 36 14% ns ns
Yes 281 52% 41 15%
Location
Urban Darwin 262 49% 43 16%
Rural Darwin 65 12% 5 8% ns ns
Remote 169 31% 22 13%
Other 44 8% 7 16%
Season
Mar–Nov 260 48% 28 11% 0.025 1.8 (1.1–2.9) ns
Dec–Feb 280 52% 49 18%
Risk factors1
None 106 20% 2 2%
Any 434 80% 75 17% ,0.001 11 (2.6–45) 0.002 9.4 (2.3–39)
1Risk factors; as listed in Table 1.
ns; not significant.
doi:10.1371/journal.pntd.0000900.t008
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that 61% of admissions during the peak monsoonal months of
December to February were with pneumonia, in comparison to
only 41% in the other 9 months, plus the recognition that
mediastinal lymphadenopathy is not uncommon.
Diabetes is the most important risk factor for melioidosis,
followed by hazardous alcohol use, chronic lung disease and
chronic renal disease [7,14,17,19,23,24,25]. Malignancy, immu-
nosuppression and thalassemia are also recognised risk factors
[24]. In the Darwin study 39% of patients were diabetic, with
nearly all having adult onset type 2 diabetes. Rates of diabetes
from other endemic locations were 57% in the largest series from
Thailand [24], 48% in Singapore [19], 60% in Taiwan [26], 38%
in bacteremic melioidosis patients in Malaysia [27] and 42% in
north Queensland, Australia [25]. When considering the estimated
prevalence of diabetes in the whole population, we previously
calculated the risk of melioidosis in diabetics in the tropical Top
End of the Northern Territory to be 21.2 (95% CI 17.1–26.3)
times the risk in non-diabetics [17], which is similar to data from
Thailand [14].
A lack of association of melioidosis with HIV infection [28,29]
supports a limited role for adaptive immunity in protection against
acquisition of and mortality from melioidosis, despite evidence for
a cell-mediated immune response to B. pseudomallei [30,31]. We
proposed that a unifying hypothesis for the predominance of
diabetes, excessive alcohol consumption and chronic renal disease
in melioidosis patients was the critical role of innate immunity and
especially robust neutrophil function in controlling infection with
B. pseudomallei [7]. The specific defects in neutrophil function in
diabetes, alcohol excess and renal disease have been well described
and were the basis for trialling therapy with granulocyte-colony
stimulating factor (G-CSF) in melioidosis [32,33]. The dysfunc-
tional neutrophil hypothesis is supported by a study in a mouse
model showing a critical role for neutrophils in resistance to
melioidosis [34] and a recent study from Thailand showing that, in
comparison to non-diabetics, otherwise healthy diabetics had
neutrophils displaying impaired phagocytosis of B. pseudomallei,
reduced migration in response to interleukin-8 and an inability to
delay apoptosis [35]. The occurrence of melioidosis in chronic
granulomatous disease also supports a key role for neutrophils
[36].
Our clinical impression is that the risk for melioidosis in those
with hazardous alcohol use may often be directly related to binge
drinking rather than chronic liver disease, with high blood alcohol
levels at the time of exposure to B. pseudomallei inhibiting protection
against bacterial propagation and dissemination. This is consistent
with earlier studies on neutrophil function in alcohol intoxication
[37,38]. An additional potential pathogenetic mechanism for more
severe disease in those with hazardous alcohol intake is the
induction by alcohol of bacterial genes encoding various potential
virulence mechanisms, as recently shown in transcriptional
profiling studies of Acinetobacter baumannii grown in the presence
of alcohol [39]. In the Darwin study hazardous alcohol use but not
diabetes was an independent predictor of presentation with
melioidosis pneumonia (Table 3). In addition to neutrophil
dysfunction, alcohol excess also adversely affects many other
components of innate pulmonary host defences, from decreased
ciliary beat frequency to impaired alveolar macrophage phagocy-
tosis and inhibited cytokine responses [40]. Various aspects of
adaptive pulmonary immunity are also affected by alcohol,
involving both cellular and humoral responses.
We have noted two comorbidities previously unrecognized as
potential risk factors for melioidosis. Chronic lung disease was an
independent predictor of pneumonic melioidosis, which may
reflect defective innate immunity such as impaired alveolar
macrophage function [41]. Rheumatic heart disease and cardiac
failure may predispose to melioidosis by similar mechanisms [42].
It is being increasingly recognised that patients with cystic
fibrosis are at substantial risk of infection with B. pseudomallei if they
live in or travel to endemic regions [43]. Chronic infection can
occur, with acute flares of pneumonia and progressive deteriora-
tion of lung function, as also seen with B. cepacia infection in cystic
fibrosis [44,45,46]. Patients with cystic fibrosis should consider
avoiding travel to locations where melioidosis is common. One
Darwin patient with cystic fibrosis has had three separate
infections with different genotypes of B. pseudomallei. In addition,
there is only 1/463 survivors in the Darwin study in whom
clearance of B. pseudomallei has not been possible. This patient has
severe bronchiectasis and has had persisting pulmonary infection
for 8 years; such inability to eradicate B. pseudomallei from sputum
has only been previously documented in cystic fibrosis [43].
Around half of melioidosis cases present with pneumonia, which
can be part of a fatal septicaemia, a less severe unilateral infection
indistinguishable from other community-acquired pneumonias or
a chronic illness mimicking tuberculosis [2,47]. In the Darwin
study mortality was 49% in those with pneumonia who also had
septic shock, in comparison to 6% in those with pneumonia
without septic shock and 4% in those with chronic pneumonia.
Early clinical descriptions and animal studies showed that
melioidosis pneumonia can follow percutaneous infection [48],
but the proportions of our pneumonia cases which were from
percutaneous exposure, inhalation or aspiration are unknown.
Nevertheless the finding of mediastinal widening on chest X-ray
and CT scan in some melioidosis patients is analogous to
inhalational anthrax.
Other presentations in the Darwin study range from skin lesions
without systemic illness [49], to overwhelming sepsis with abscesses
disseminated in multiple internal organs. Genitourinary [11],
bone, joint and neurological infections [50,51,52] are all well
recognised. One manifestation of melioidosis commonly seen in
Thailand [53], but not seen over the 20 years of the Darwin study
is children presenting with parotid abscesses. The reasons for this
difference remain unclear.
The dramatic presentation of melioidosis brainstem encephalitis
or myelitis has been noted to be more commonly seen in Australia
than in Thailand [1,3]. Recent mouse studies have suggested that
such neurological presentations may result from direct entry of B.
pseudomallei to the brain from the nasal mucosa via the olfactory
nerve or similar pathways [54]. Genetic differences between B.
pseudomallei strains may account for regional clinical variations. It
was recently demonstrated that the global B. pseudomallei
population probably evolved from an ancestral Australian
population which subsequently spread to Southeast Asia [55].
One possible explanation for the neurological disease being more
common in Australia is differences in propensity between B.
pseudomallei populations for actin-based motility of bacteria along
nerve pathways, conferred by variants of the BimA gene which
have been found to be geographically restricted [56]. The concept
of direct brain invasion by B. pseudomallei in the Darwin cases of
primary melioidosis meningo-encephalomyelitis is supported by
the low bacteremia rate in comparison to all 8 of those with
secondary brain infections being bacteremic.
Most of the less common presentations of melioidosis seen in the
Darwin study have also been described from other locations.
These include mycotic aneurysms [57], epididymo-orchitis [58],
pericarditis [59] and mastitis with maternal to child transmission
of melioidosis [4]. The common presence of diverse internal organ
abscesses necessitating routine imaging is also well recognised
[1,60,61]. In contrast to Thai studies, where spleen and liver
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abscesses predominate [60], prostate abscesses were extremely
common in the Darwin series, being present in 76/372 (20%)
males. While liver, spleen and renal abscesses responded to
prolonged antibiotic therapy, prostatic abscesses usually required
drainage, whether primary or secondary [11]. Although unusual,
the presence of para-intestinal masses supports that ingestion can
occasionally be the primary route of infection in humans, as is
more commonly seen in grazing animals [62].
Whatever the initial clinical presentation, secondary foci of
infection are common in melioidosis (Table 5), presumably from
bacteremic spread and reflecting the high rate of bacteremia
overall (55%). Of those 59 patients presenting with bacteremia
without an apparent focus, 25 (42%) subsequently developed an
evident secondary focus of infection. Secondary pneumonia and
septic arthritis were especially common.
Therapy of melioidosis requires prolonged antibiotics to cure
infection and prevent relapse [63]. In the Darwin study 25/465
(5.4%) patients who survived the initial infection relapsed after
treatment, with a median time to relapse of 8 months from initial
admission, in comparison to 86/889 (9.7%) and 6 months from
commencement of oral therapy in Thailand [24]. Choice and
duration of and compliance with antibiotic therapy were the
strongest indicators of risk for relapse in both locations. Diabetes
was significantly associated with risk for relapse in the Darwin
series but not in Thailand, while in both locations bacteremia on
initial admission was associated with relapse, although only
significantly so in Thailand.
Genotyping of B. pseudomallei from recurrent melioidosis has
shown that reinfection can also occur but is less common than
relapse [24,64]. In northeast Thailand reinfection occurred in 30/
899 (3.4%) patients, making the incidence of melioidosis
reinfection substantially higher than that of primary infection
[24]. This is in contrast to the Darwin patients, where reinfection
was documented in only 4/465 (1%), despite most having
persisting risk factors and continuing exposure and even raising
the possibility of some acquired immunity to reinfection following
melioidosis. Simultaneous infection with more than one strain of
B. pseudomallei has been shown to very uncommon (2/133 cases in
Thailand) [65], but was thought likely in one of the patients in this
study.
Mortality from melioidosis in the Darwin study was 14%, with
75 of the 77 deaths occurring during the initial hospital admission
and only 2 deaths from relapsed melioidosis. Mortality during the
first 5 years of the study (from October 1989) was 30% and during
the last 5 years (until October 2009) was 9% (p,0.001). These
rates compare with 49% mortality in the large Thai study from
1986–2004 [24], with mortality now decreasing in that region
[18], 65% in bacteremic patients in Malaysia during 1976–1991
[27], 16% in Singapore between 1998–2007 [19], 22% in Taiwan
between 2000 and 2005 [26] and 25% in north Queensland
between 1996 and 2004 [25].
The decreasing mortality over the 20 years of the Darwin study
cannot be attributed to ascertainment bias from improved
diagnosis of less severe cases. Indeed, the bacteremia rate was
higher in the last 5 years (66%), possibly reflecting both more
frequent repeat culturing in suspected cases and improved
laboratory detection of low level bacteremia. The median age,
rates of septic shock, percentages with various risk factors and the
proportion with no risk factors did not change significantly over
the 20 years (Table 6). The overall bacteremia rate of 55%
compares with up to 65% in Thailand [24][66], 50% in Singapore
[19] and 60% in north Queensland [25].
We attribute the improved survival over time to a combination
of earlier diagnosis of melioidosis through increased community
and health staff awareness of the possibility, earlier treatment with
ceftazidime or meropenem [67] and probably most importantly,
access to and improvements in intensive care management of the
septic patient. In many melioidosis-endemic regions renal
replacement therapy and other resources for managing the
metabolic abnormalities and organ dysfunction seen in severe
sepsis are limited and without these mortality in septicemic
melioidosis will remain high [2,24,68]. A greater proportion of
patients were ventilated in the second half of the Darwin study and
mortality in patients with septic shock was 100% in the first five
years and decreased to 27% in the last 5 years (Table 6). Our
initial optimism of potential benefit from G-CSF therapy in
septicemic melioidosis [32] has been tempered by a randomized
controlled trial in Thailand which showed that G-CSF conferred
no mortality benefit in severe melioidosis in that setting [33].
Nevertheless those treated with G-CSF in that study had a longer
duration of survival, suggesting that if state-of-the-art ICU therapy
is available G-CSF may be beneficial.
A decrease in mortality in melioidosis similar to that seen in
Darwin has also occurred in Singapore, where mortality in 1989–
1996 was 40% in comparison to the more recent 16% [19]. It is
notable that during the more recent series from Singapore there
was a period in March–April 2004 with case numbers, proportion
with pneumonia (83%) and mortality (53%) all higher than at
other times [19]. This cluster of cases followed heavy rainfall and
strong winds. Genotyping showed a diversity of strains, excluding
a point source outbreak and the severe disease in this cluster was
attributed to a possible shift to inhalation of aerosolized B.
pseudomallei [19,69]. This is analogous to clusters seen in the
Darwin study following severe weather events [9].
This study provides strong support for the presence of specific
host risk factors being the most important determinant of mortality
from melioidosis. Older age is also recognised as a risk factor for
melioidosis [14,17,19] and in the Darwin study age $50 years was
an independent predictor of death from melioidosis (Table 8). Of
the 77 deaths from melioidosis over the 20 years, 2 were in elderly
patients without other evident risk factors and all of the other 75
fatal cases had at least one of the specific recognised risk factors
listed in Table 1. That severe disease is very uncommon in
melioidosis in patients without risk factors is evident from the
much lower rates of bacteremia (22%) and septic shock (6%) in
these patients in the Darwin study. The association of diabetes
with bacteremia in patients with melioidosis has been noted in
Thailand [23]. Nevertheless, while all the listed risk factors
including diabetes were independently associated with bacteremia
in the Darwin study (Table 7), no individual risk factor apart from
age was an independent predictor of mortality. This reflects that
80% of melioidosis cases in the Darwin study had at least one risk
factor irrespective of age and it was the presence of any of these
risk factors that was highly predictive of mortality (OR 9.4; 95%
CI 2.3–39).
Although the higher proportion of presentations with pneumo-
nia during the peak monsoonal months of December to February
supports a role for inhalation and although mortality was higher
on univariate analysis during these 3 months, multivariate analysis
showed that seasonality was not itself a significant independent
predictor of mortality (Table 8). Furthermore, while severe
melioidosis is associated with an array of pathogen induced
immune dysregulation [70], that no death occurred in a patient
without risk factors does not support an important role for
cytokine-related human genetic polymorphisms in determining
outcomes in melioidosis [71]. Therefore, although disease may be
more severe following inhalation and/or higher infecting load of
B. pseudomallei, the only predictor of mortality from melioidosis is
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the presence of defined risk factors such as diabetes, hazardous
alcohol use, chronic lung or renal disease and older age.
In conclusion, melioidosis should be more seen as an
opportunistic pathogen that is very unlikely to kill a healthy
person, provided the infection is diagnosed early and resources are
available to provide appropriate antibiotics and critical care where
required.
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